DBV Technologies S.A. – Filings and Transcripts

NASDAQ: DBVT
Share price (10/2/26): $10.55
Market cap (10/2/26): $624 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

MPM BioImpact LLC

Ra Capital Management, L.P.

Mohideen Pharis

MPM BioImpact LLC

Artisan Partners Limited Partnership

News Filter

Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

Reports Second Quarter and Half-Year 2026 Financial Results and Business Update

Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 Through 7 Years; Working Collaboratively With FDA to Optimize Review Process in Preparation for Filing

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission